132 related articles for article (PubMed ID: 34096882)
21. Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene.
Griniatsos JE; Dimitriou N; Zilos A; Sakellariou S; Evangelou K; Kamakari S; Korkolopoulou P; Kaltsas G
World J Surg Oncol; 2011 Jan; 9():6. PubMed ID: 21266030
[TBL] [Abstract][Full Text] [Related]
22. Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.
Simon DP; Hammer GD
Mol Cell Endocrinol; 2012 Mar; 351(1):2-11. PubMed ID: 22266195
[TBL] [Abstract][Full Text] [Related]
23. Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report.
Bondy S; Tajzler C; Hotte SJ; Kapoor A; Zbuk K; Lalani AA
Curr Oncol; 2020 Dec; 28(1):226-232. PubMed ID: 33704190
[TBL] [Abstract][Full Text] [Related]
24. A rare association of two endocrine tumours: non-functional oncocytic adrenocortical carcinoma and Papillary thyroid carcinoma.
Ruiz-Sánchez JG; Parra Ramírez P; Lisbona Catalán A
Horm Mol Biol Clin Investig; 2021 Mar; 42(2):199-201. PubMed ID: 33675218
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.
Korah R; Healy JM; Kunstman JW; Fonseca AL; Ameri AH; Prasad ML; Carling T
Mol Cancer; 2013 Aug; 12():87. PubMed ID: 23915220
[TBL] [Abstract][Full Text] [Related]
26. Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.
Raygada M; Raffeld M; Bernstein A; Miettinen M; Glod J; Hughes MS; Reilly K; Widemann B; Del Rivero J
Am J Med Genet A; 2021 Apr; 185(4):1282-1287. PubMed ID: 33615670
[TBL] [Abstract][Full Text] [Related]
27. Adrenocortical carcinoma is a lynch syndrome-associated cancer.
Raymond VM; Everett JN; Furtado LV; Gustafson SL; Jungbluth CR; Gruber SB; Hammer GD; Stoffel EM; Greenson JK; Giordano TJ; Else T
J Clin Oncol; 2013 Aug; 31(24):3012-8. PubMed ID: 23752102
[TBL] [Abstract][Full Text] [Related]
28. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
29. Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome.
Medina-Arana V; Delgado L; González L; Bravo A; Díaz H; Salido E; Riverol D; González-Aguilera JJ; Fernández-Peralta AM
Fam Cancer; 2011 Jun; 10(2):265-71. PubMed ID: 21225464
[TBL] [Abstract][Full Text] [Related]
30. Adrenocortical cancer cell line mutational profile reveals aggressive genetic background.
Nicolson NG; Korah R; Carling T
J Mol Endocrinol; 2019 May; 62(4):179-186. PubMed ID: 30870809
[TBL] [Abstract][Full Text] [Related]
31. Adrenocortical Carcinoma Steroid Profiles:
Muzzi JCD; Magno JM; Cardoso MA; de Moura J; Castro MAA; Figueiredo BC
Front Endocrinol (Lausanne); 2021; 12():672319. PubMed ID: 34194394
[TBL] [Abstract][Full Text] [Related]
32. A novel case of myxoid variant of adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1.
Harada K; Yasuda M; Hasegawa K; Yamazaki Y; Sasano H; Otsuka F
Endocr J; 2019 Aug; 66(8):739-744. PubMed ID: 31118348
[TBL] [Abstract][Full Text] [Related]
33. [Identification of a novel TP53 germline mutation in one child with adrenocortical carcinoma].
Si N; Sun M; Lu CX; Liu YS; Qi Z; Yang W; Zhao XL; Zhang X
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1402-4. PubMed ID: 19671334
[TBL] [Abstract][Full Text] [Related]
34. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
[TBL] [Abstract][Full Text] [Related]
35. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
36. Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Gara SK; Wang Y; Patel D; Liu-Chittenden Y; Jain M; Boufraqech M; Zhang L; Meltzer PS; Kebebew E
Nucleic Acids Res; 2015 Oct; 43(19):9327-39. PubMed ID: 26446994
[TBL] [Abstract][Full Text] [Related]
37. Clinical impact of TP53 alterations in adrenocortical carcinomas.
Waldmann J; Patsalis N; Fendrich V; Langer P; Saeger W; Chaloupka B; Ramaswamy A; Fassnacht M; Bartsch DK; Slater EP
Langenbecks Arch Surg; 2012 Feb; 397(2):209-16. PubMed ID: 22203015
[TBL] [Abstract][Full Text] [Related]
38. Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.
Gagnon N; Boily P; Alguire C; Corbeil G; Bancos I; Latour M; Beauregard C; Caceres K; El Haffaf Z; Saad F; Olney HJ; Bourdeau I
Endocrine; 2020 Apr; 68(1):203-209. PubMed ID: 32088909
[TBL] [Abstract][Full Text] [Related]
39. Management of Adrenocortical Carcinoma.
Jasim S; Habra MA
Curr Oncol Rep; 2019 Feb; 21(3):20. PubMed ID: 30798468
[TBL] [Abstract][Full Text] [Related]
40. Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis.
Barreiro RAS; Sabbaga J; Rossi BM; Achatz MIW; Bettoni F; Camargo AA; Asprino PF; A F Galante P
J Pathol; 2022 Feb; 256(2):214-222. PubMed ID: 34816434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
